MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/1354750x.2018.1423706

Медицинская библиотека · Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals · 2018

Determinants of elevated carbohydrate antigen 125 in patients with severe symptomatic aortic valve stenosis referred for transcatheter aortic valve implantation.

Rheude Tobias, Pellegrini Costanza, Reinhard Wibke, Trenkwalder Teresa, Koenig Wolfgang, Mayr N Patrick, Joner Michael, Núñez Julio, Holdenrieder Stefan, Schunkert Heribert, Kastrati Adnan, Hengstenberg Christian, Husser Oliver

СтатьяПеревод в очереди

Аннотация

PURPOSE: Elevated carbohydrate antigen 125 (CA125) predicts adverse outcome after transcatheter aortic valve implantation (TAVI). While known underlying pathophysiological mechanisms of elevated CA125 include serosal effusions and inflammatory stimuli, clinical determinants associated with elevated CA125 in patients referred for TAVI remain unknown. Therefore, we investigated clinical, laboratory and echocardiographic determinants of elevated CA125 in patients with severe aortic valve stenosis referred for TAVI.

METHODS

This study includes 650 patients with severe aortic stenosis referred for TAVI. Baseline CA125 was determined by an immunoassay and dichotomized (elevated versus normal) based on the manufacturer cutoff value (>35 U/mL).

RESULTS

CA125 elevation was present in 28% (181/650). Patients with elevated CA125 had an overall worse clinical profile and were more symptomatic with a higher rate of NYHA class III/IV (80% versus 58%; p < 0.001). In a multivariate analysis, independent predictors of elevated CA125 were New York Heart Association (NYHA) class, baseline hemoglobin, C-reactive protein (CRP), left ventricular ejection fraction and severe tricuspid regurgitation.

CONCLUSION

Elevated CA125 levels in patients referred for TAVI summarize a subset of patients with an overall worse clinical profile who are more symptomatic.

Для цитирования: Rheude Tobias, Pellegrini Costanza, Reinhard Wibke, Trenkwalder Teresa, Koenig Wolfgang, Mayr N Patrick, Joner Michael, Núñez Julio, Holdenrieder Stefan, Schunkert Heribert, Kastrati Adnan, Hengstenberg Christian, Husser Oliver. Determinants of elevated carbohydrate antigen 125 in patients with severe symptomatic aortic valve stenosis referred for transcatheter aortic valve implantation.. Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals. 2018. DOI: 10.1080/1354750x.2018.1423706.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.